Ketanserin improves cardiac performance after myocardial infarction in spontaneously hypertensive rats partially through restoration of baroreflex function

Acta Pharmacologica Sinica

Volumn 34, Issue 12, 2013, Pages 1508-1514

  Yu, Jian Guang ^a   Zhang, En Hui ^a   Liu, Ai Jun ^a   Liu, Jian Guo ^a   Cai, Guo Jun ^a   Su, Ding Feng ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Angiogenesis; Baroreflex; Ketanserin; Myocardial infarction; 7 nAChR

Indexed keywords

ATROPINE; BUNGAROTOXIN RECEPTOR; KETANSERIN; VASCULOTROPIN; VESICULAR ACETYLCHOLINE TRANSPORTER; ACETYLCHOLINE; VASCULOTROPIN A;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD FLOW; BLOOD PRESSURE; CAPILLARY DENSITY; CORONARY ARTERY LIGATION; DRUG RESPONSE; HEART EJECTION FRACTION; HEART FUNCTION; HEART INFARCTION; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE ISCHEMIA; HEART PERFORMANCE; HEART RATE; HEART VENTRICLE REMODELING; LEFT CORONARY ARTERY; NONHUMAN; PRESSORECEPTOR REFLEX; PROTEIN EXPRESSION; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; SYSTOLIC BLOOD PRESSURE; TREATMENT RESPONSE; VAGUS TONE; ANIMAL; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; HEART; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY;

ACETYLCHOLINE; ANIMALS; BAROREFLEX; ENZYME-LINKED IMMUNOSORBENT ASSAY; HEART; KETANSERIN; MYOCARDIAL INFARCTION; RATS; RATS, INBRED SHR; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84901539617     PISSN: 16714083     EISSN: 17457254     Source Type: Journal    
DOI: 10.1038/aps.2013.147     Document Type: Article

References (42)

1. Roger VL, Go AS, Lloyd-Jones DM, Benjamin EJ, Berry JD, Borden WB, et al. Executive summary: heart disease and stroke statistics - 2012 update: A report from the American Heart Association. Circulation 2012; 125:188-97.
2. Norris RM, Barnaby PF, Brandt PW, Geary GG, Whitlock RM, Wild CJ, et al. Prognosis after recovery from first acute myocardial infarction: determinants of reinfarction and sudden death. Am J Cardiol 1984; 53:408-13.
3. Califf RM, Phillips HR 3rd, Hindman MC, Mark DB, Lee KL, Behar VS, et al. Prognostic value of a coronary artery jeopardy score. J Am Coll Cardiol 1985; 5:1055-63.
4. Bigger JT Jr, Fleiss JL, Kleiger R, Miller JP, Rolnitzky LM. The relationships among ventricular arrhythmias, left ventricular dysfunction, and mortality in the 2 years after myocardial infarction. Circulation 1984; 69: 250-8.
5. Billman GE, Schwartz PJ, Stone HL. Baroreceptor reflex control of heart rate: A predictor of sudden cardiac death. Circulation 1982; 66: 874-80.
6. Schwartz PJ, Vanoli E, Stramba-Badiale M, De Ferrari GM, Billman GE, Foreman RD. Autonomic mechanisms and sudden death. New insights from analysis of baroreceptor reflexes in conscious dogs with and without a myocardial infarction. Circulation 1988; 78:969-79.
7. La Rovere MT, Specchia G, Mortara A, Schwartz PJ. Baroreflex sensitivity, clinical correlates, and cardiovascular mortality among patients with a first myocardial infarction. A prospective study. Circulation 1988; 78:816-24.
8. La Rovere MT, Bigger JT Jr, Marcus Fl, Mortara A, Schwartz PJ. Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. ATRAMI (Autonomic Tone and Reflexes After Myocardial Infarction) Investigators. Lancet 1998; 351: 478-84.
9. De Ferrari GM, Sanzo A, Bertoletti A, Specchia G, Vanoli E, Schwartz PJ. Baroreflex sensitivity predicts long-term cardiovascular mortality after myocardial infarction even in patients with preserved left ventricular function. J Am Coll Cardiol 2007; 50: 2285-90.
10. La Rovere MT, Bersano C, Gnemmi M, Specchia G, Schwartz PJ. Exercise-induced increase in baroreflex sensitivity predicts improved prognosis after myocardial infarction. Circulation 2002; 106:945-9.
11. Jorge L, Rodrigues B, Rosa KT, Malfitano C, Loureiro TC, Medeiros A, et al. Cardiac and peripheral adjustments induced by early exercise training intervention were associated with autonomic improvement in infarcted rats: role in functional capacity and mortality. Eur Heart J 2011; 32: 904-12.
12. Fu YJ, Shu H, Miao CY, Wang MW, Su DF. Restoration of baroreflex function by ketanserin is not blood pressure dependent in conscious freely moving rats. J Hypertens 2004; 22:1165-72.
13. Xie HH, Shen FM, Cao YB, Li HL, Su DF. Effects of low-dose ketanserin on blood pressure variability, baroreflex sensitivity and end-organ damage in spontaneously hypertensive rats. Clin Sci (Lond) 2005; 108: 547-52.
14. Miao CY, Xie HH, Yu H, Chu ZX, Su DF. Ketanserin stabilizes blood pressure in conscious spontaneously hypertensive rats. Clin Exp Pharmacol Physiol 2003; 30:189-93.
15. 2A receptors. Clin Exp Pharmacol Physiol 2007; 34: 702-7.
16. Landmesser U, Wollert KC, Drexler H. Potential novel pharmacological therapies for myocardial remodelling. Cardiovasc Res 2009; 81: 519-27.
17. Tongers J, Losordo DW, Landmesser U. Stem and progenitor cell- based therapy in ischaemic heart disease: promise, uncertainties, and challenges. Eur Heart J 2011; 32:1197-206.
18. Yu JG, Song SW, Shu H, Fan SJ, Liu AJ, Liu C, et al. Baroreflex deficiency hampers angiogenesis after myocardial infarction via acetylcholine- A7-nicotinic ACh receptor in rats. Eur Heart J 2013; 34: 2412-20.
19. Yu JG, Wu J, Shen FM, Cai GJ, Liu JG, Su DF. Arterial baroreflex dysfunction fails to mimic Parkinson's disease in rats. J Pharmacol Sci 2008; 108: 56-62.
20. Liu AJ, Zang P, Guo JM, Wang W, Dong WZ, Guo W, et al. Involvement of acetylcholine-alpha7nAChR in the protective effects of arterial baroreflex against ischemic stroke. CNS Neurosci Ther 2012; 18: 918-26.
21. Yang YL, Yu LT, Wu ZT, Yu JG, Zhang JM, Chen QH, et al. Synergic effects of levamlodipine and bisoprolol on blood pressure reduction and organ protection in spontaneously hypertensive rats. CNS Neurosci Ther 2012; 18:471-4.
22. Kumarswamy R, Lyon AR, Volkmann I, Mills AM, Bretthauer J, Pahuja A, et al. SERCA2a gene therapy restores microRNA-1 expression in heart failure via an Akt/Fox03A-dependent pathway. Eur Heart J 2012; 33:1067-75.
23. 11C-PK11195 positron emission tomography/computed tomography. Eur Heart J 2012; 33:1902-10.
24. Quarta G, Syrris P, Ashworth M, Jenkins S, Zuborne Alapi K, Morgan J, et al. Mutations in the Lamin A/C gene mimic arrhythmogenic right ventricular cardiomyopathy. Eur Heart J 2012; 33:1128-36.
25. Ma J., Xiong JY, Hou WW, Yan HJ, Sun Y., Huang SW, et al. Protective effect of carnosine on subcortical ischemic vascular dementia in mice. CNS Neurosci Ther 2012; 18: 745-53.
26. Cheong SJ, Lee CM, Kim EM, Uhm TB, Jeong HJ, Kim DW, et al. Evaluation of the therapeutic efficacy of a VEGFR2-blocking antibody using sodium-iodide symporter molecular imaging in a tumor xenograft model. Nucl Med Biol 2011; 38: 93-101.
27. Faintuch BL, Teodoro R, Oliveira EA, Nunez EG, Faintuch J. Neovascularization after ischemic injury: evaluation with 99mTc-HYNIC-RGD. Acta Cir Bras 2011; 26: 58-63.
28. Selejan S, Poss J, Walter F, Hohl M, Kaiser R, Kazakov A, et al. Ischaemia-induced up-regulation of Toll-like receptor 2 in circulating monocytes in cardiogenic shock. Eur Heart J 2012; 33:1085-94.
29. Zou YX, Zhang XH, Su FY, Liu X. Importance of riboflavin kinase in the pathogenesis of stroke. CNS Neurosci Ther 2012; 18: 834-40.
30. Ma XJ, Cheng JW, Zhang J, Liu AJ, Liu W, Guo W, et al. E-selectin deficiency attenuates brain ischemia in mice. CNS Neurosci Ther 2012; 18:903-8.
31. Szardien S, Nef HM, Voss S, Troidl C, Liebetrau C, Hoffmann J, et al. Regression of cardiac hypertrophy by granulocyte colony-stimulating factor-stimulated interleukin-lbeta synthesis. Eur Heart J 2012; 33: 595-605.
32. Liao Y, Bin J, Asakura M, Xuan W, Chen B, Huang Q, et al. Deficiency of type 1 cannabinoid receptors worsens acute heart failure induced by pressure overload in mice. Eur Heart J 2012; 33:3124-33.
33. Lo M, Su DF, Julien C, Cerutti C, Vincent M, Sassard J. Influence of hypertension and age on the sympathetic and parasympathetic components of cardiac baroreflex in the conscious rat. Arch Mai Coeur Vaiss 1988; 81 Spec No: 113-7.
34. Billman GE, Hoskins RS. Time-series analysis of heart rate variability during submaximal exercise. Evidence for reduced cardiac vagal tone in animals susceptible to ventricular fibrillation. Circulation 1989; 80: 146-57.
35. Li DJ, Evans RG, Yang ZW, Song SW, Wang P, Ma XJ, et al. Dysfunction of the cholinergic antiinflammatory pathway mediates organ damage in hypertension. Hypertension 2011; 57: 298-307.
36. Fletcher PJ, Pfeffer JM, Pfeffer MA, Braunwald E. Effects of hypertension on cardiac performance in rats with myocardial infarction. Am J Cardiol 1982; 50:488-96.
37. Chen H, Chen SC, Zhang TH, Tian HC, Guan Y, Su DF. Protective effects of silybin and tetrandrine on the outcome of spontaneously hypertensive rats subjected to acute coronary artery occlusion. Int J Cardiol 1993; 41:103-8.
38. Emanueli C, Salis MB, Stacca T, Gaspa L, Chao J, Chao L, et al. Rescue of impaired angiogenesis in spontaneously hypertensive rats by intramuscular human tissue kallikrein gene transfer. Hypertension 2001; 38:136-41.
39. Takeshita S, Tomiyama H, Yokoyama N, Kawamura Y, Furukawa T, Ishigai Y, et al. Angiotensin-converting enzyme inhibition improves defective angiogenesis in the ischemic limb of spontaneously hypertensive rats. Cardiovasc Res 2001; 52: 314-20.
40. Heeschen C, Weis M, Aicher A, Dimmeler S, Cooke JP. A novel angiogenic pathway mediated by non-neuronal nicotinic acetylcholine receptors. J Clin Invest 2002; 110:527-36.
41. Duerschmied D, Ahrens I, Mauler M, Brandt C, Weidner S, Bode C, et al. Serotonin antagonism improves platelet inhibition in clopidogrel low-responders after coronary stent placement: An In vitro pilot study. PLoS One 2012; 7: e32656.
42. 2A receptors. J Mol Cell Cardiol 2009; 46: 518-25.